MAALOX PLUS TABLET

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

POLYMETHYLSILOXANE,ACTIVATED/SIMETHICONE; Magnesium Hydroxide; ALUMINIUM HYDROXIDE

Boleh didapati daripada:

DKSH MALAYSIA SDN BHD

INN (Nama Antarabangsa):

POLYMETHYLSILOXANE,ACTIVATED/SIMETHICONE; Magnesium Hydroxide; ALUMINIUM HYDROXIDE

Unit dalam pakej:

100Tablet Tablets; 10 Tablet Tablets; 40 Tablets

Dikeluarkan oleh:

Sanofi S.r.I.

Risalah maklumat

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
1
_ _
MAALOX
® PLUS TABLET
_ _
_ _
Magnesium Hydroxide/Aluminium Hydroxide/Simethicone
(200mg/200mg/26.25mg)
_ _
WHAT IS IN THIS LEAFLET
1. What Maalox
®
Plus is used for
2. How Maalox
®
Plus works
3. Before you use Maalox
®
Plus
4. How to use Maalox
®
Plus
5. While you are using it
6. Side effects
7. Storage and Disposal of Maalox
®
Plus
8. Product Description
9.
Manufacturer and Product
Registration Holder
10. Date of revision
WHAT MAALOX
® PLUS IS USED FOR
To provide symptomatic relief of
hyperacidity plus alleviation of gas
symptoms associated with stomach or
intestinal ulcer, gastric inflammation,
heartburn, or gas pain after operation.
To provide symptomatic relief of
abdominal bloating.
HOW MAALOX
® PLUS WORKS
Maalox
®
Plus is a balanced mixture of
two antacids, aluminium hydroxide is a
slow antacid and magnesium hydroxide
is a quick acting one. Simethicone is a
gastric defoaming agent, used to
combine lots of small bubbles into
larger bubbles, which can be expelled
more easily.
BEFORE YOU USE MAALOX
® PLUS
-
_When you must not use it _
-
Hypersensitivity to active substance
or any of the excipients. Signs of an
allergic reaction are skin rash,
swelling of the lips, tongue, face and
throat; and breathing problems
-
Porphyria
-
Serious kidney problems
-
Children
-
Cachexia
-
_Before you start to use it_
Maalox
®
Plus Tablet is not
recommended for children.
Inform your doctor if you have kidney
disease.
_Pregnancy _
Maalox
®
Plus should only be used
when absolutely necessary. Consult
your doctor to make an evaluation of
the expected benefit for the mother in
relation to the risk for the fetus or
baby.
_Lactation _
Maalox® Plus is considered compatible
with breast-feeding.
-
_Taking other medicines_
Tell your doctor or pharmacist if you
are taking, have recently taken or might
take any other medicines, including any
that you buy without a prescription
from a pharmacy, supermarket or health
food shop.
Some drugs may be affected by
magnesium hydrox

Ciri produk

MY/MAA/0322/SmPC1219
MAALOX® PLUS TABLET
COMPOSITION:
To provide symptomatic relief of hyperacidity plus alleviation of gas
symptoms, each tablet contains:
Maalox® Plus
Active Ingredients
Per Tablet
Magnesium Hydroxide
200mg
Aluminium Hydroxide
200mg
Simethicone (equivalent to Dimethicone)
26.25mg (25mg)
PHARMACOLOGICAL PROPERTIES:
PHARMACODYNAMIC PROPERTIES
Pharmacotherapeutic group: Antacids with antiflatulents; ATC code:
A02AF02.
Mechanism of action
The antacid effect takes place in the stomach where, at the
appropriate dose, magnesium hydroxide and
aluminum hydroxide neutralize gastric acid production.
The constipating effect of aluminum hydroxide is counteracted by the
laxative effect of magnesium
hydroxide.
Simeticone has an antiflatulent effect.
PHARMACOKINETIC PROPERTIES
Absorption
When administered orally, aluminum hydroxide and magnesium hydroxide
react with the hydrochloric
acid produced in the stomach to form salts, which are only partly
absorbed.
Excretion
Absorbed salts are excreted mainly in the urine.
INDICATIONS: As an antacid for symptomatic relief of hyperacidity
associated with the diagnosis of peptic
ulcer, gastritis, peptic esophagitis, gastric hyperacidity, heartburn,
or hiatal hernia.
As an antiflatulent to alleviate the symptoms of gas, including
postoperative gas pain.
DIRECTIONS FOR USE: Two to four tablets, well chewed, four times a
day, taken twenty minutes to one
hour after meals and at bedtime, or as directed by a physician.
Maalox® Plus are not recommended for children.
ADVERSE EFFECTS: The frequency of the undesirable effects listed below
is defined using the following
conventions:
Common (≥1/100 to <1/10); uncommon (≥1/1 000 to <1/100); rare
(≥1/10 000 to <1/1 000); very rare
(<1/10 000); not known (cannot be estimated from the available data).
_Immune system disorders: _
_Frequency not known: _angioedema, anaphylactic reactions,
hypersensitivity reactions, urticaria, pruritus.
MY/MAA/0322/SmPC1219
_Gastrointestinal disorders: _
_Uncommon_: diarrhea or constipation.
_Fre